Showing results (91-100 of 404) with videos related to
Sort By:
Pageof 41
Journal of the National Comprehensive Cancer Network : JNCCN|September 30, 2020
Telemedicine in Oncology and Reimbursement Policy During COVID-19 and BeyondSheetal M Kircher, Mary Mulcahy, Aparna Kalyan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: phase II trial (E8296) of the Eastern Cooperative Oncology GroupMary Armanios, Ronghui Xu, Arlene A Forastiere, et al.Oncology|July 16, 2005
A phase I study of docetaxel, Cisplatin, 5-Fluorouracil and leucovorinMary F Mulcahy, Patrick J Loehrer, Neal J Meropol, et al.Scandinavian Journal of Work, Environment & Health|February 21, 2015
Enhanced preference for high-fat foods following a simulated night shiftSean W Cain, Ashleigh J Filtness, Craig L Phillips, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapyLanlan Shen, Paul J Catalano, Al B Benson, et al.Journal of Clinical and Experimental Neuropsychology|November 24, 2015
Sleep disturbance and deficits of sustained attention following strokeSamuel C Pearce, Renerus J Stolwyk, Peter W New, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 27, 2020
Preoperative assessment of lymph node metastasis in Colon Cancer patients using machine learning: a pilot studyAydin Eresen, Yu Li, Jia Yang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sitesPatrick G Johnston, Al B Benson, Paul Catalano, et al.The Oncologist|March 2, 2017
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic AdenocarcinomaAl B Benson, Zev A Wainberg, J Randolph Hecht, et al.Expert Review of Anticancer Therapy|October 18, 2011
Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patientsSheetal M Kircher, Seth B Krantz, Halla S Nimeiri, et al.Pageof 41